Company Filing History:
Years Active: 2006-2024
Title: The Innovative Contributions of Theresa Marie LaVallee
Introduction
Theresa Marie LaVallee is a prominent inventor based in Rockville, MD, known for her significant contributions to the field of medical research. With a total of seven patents to her name, she has made remarkable strides in the treatment of eosinophil and mast cell-related disorders. Her work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Among her latest patents, LaVallee has developed methods and uses involving antibodies that specifically bind to a KIT receptor tyrosine kinase. These innovations are aimed at managing, treating, or preventing eosinophil or mast cell-related disorders, particularly those affecting the nervous system. This includes conditions such as neuromyelitis optica (NMO), neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and neurofibromatosis (NF). Her research is crucial in advancing therapeutic options for patients with these challenging disorders.
Career Highlights
Throughout her career, LaVallee has worked with notable companies such as Entremed, Inc. and Celldex Therapeutics Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research initiatives.
Collaborations
LaVallee has collaborated with esteemed colleagues, including Gregory E. Agoston and Jamshed H. Shah. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Theresa Marie LaVallee's contributions to medical research and her innovative patents highlight her dedication to improving treatment options for eosinophil and mast cell-related disorders. Her work continues to inspire advancements in the field and offers hope to many patients.